| 27 Aug 2011 | New frontiers and emerging paradigms for cardiovascular risk reduction in the setting of type 2 diabetes | 12:00- 13:30 | Berne - Zone E | Antithrombotic agents |
| 27 Aug 2011 | DAPT (Dual AntiPlatelet Therapy) for acute coronary syndromes/percutaneous coronary intervention patients: from evidence to real world experience | 14:30- 16:00 | Madrid - Zone D | Antithrombotic agents |
| 27 Aug 2011 | Acute coronary syndromes: translating clinical trial results into real-world clinical practice | 14:30- 16:00 | Budapest - Zone E | Antithrombotic agents |
| 27 Aug 2011 | Le patient post-syndrome coronaire aigu - focus sur les cibles thérapeutiques et les antiplaquettaires / The post-acute coronary syndrome patient - focus on therapeutic targets and antiplatelet drugs | 11:30- 12:30 | Athens - Zone F | Post infarction period |
| 27 Aug 2011 | New and present concepts in stem cell therapy. | 14:30- 16:00 | Lisbon - Zone D | Stem cells and cell therapy |
| 28 Aug 2011 | Anatomical and functional imaging of coronary artery disease - Live from Finland | 08:30- 10:00 | London - Zone A | Angina pectoris stable |
| 28 Aug 2011 | Ischaemic heart disease in women: why do we manage them differently? | 14:00- 15:30 | Riga - Zone B | Angina pectoris stable |
| 28 Aug 2011 | Early diagnosis and management of chest pain | 14:00- 15:30 | The Hague - Zone A | Angina pectoris unstable |
| 28 Aug 2011 | Improving compliance with low-dose acetylsalicylic acid (ASA) - New insights | 12:45- 13:30 | Ankara - Zone F | Antithrombotic agents |
| 28 Aug 2011 | Percutaneous valve implantation or operation in aortic stenosis? | 12:45- 13:45 | Berne - Zone E | Aortic valve disease |
| 28 Aug 2011 | Controversies in low-flow low-gradient aortic stenosis | 16:30- 18:00 | Budapest - Zone E | Aortic valve disease |
| 28 Aug 2011 | Poster session 1: Risk factor, biomarkers and comorbidities in the management of acute and chronic ischaemic heart disease | 08:30- 12:30 | Posters - Poster Zone C | CAD and comorbidities |
| 28 Aug 2011 | Anaemia in heart disease | 08:30- 10:00 | Athens - Zone F | CAD and comorbidities |
| 28 Aug 2011 | Update on cardiorenal syndrome | 16:30- 18:00 | Ankara - Zone F | CAD and comorbidities |
| 28 Aug 2011 | Stent for Life: how to increase the penetration of primary angioplasty in Europe? | 08:30- 10:00 | Tunis - Zone F | Infarction acute phase STEMI |
| 28 Aug 2011 | Sound and light in the cath lab | 14:00- 15:30 | Belgrade - Zone F | Invasive coronary imaging |
| 28 Aug 2011 | Poster session 1: Non coronary cardiovascular interventions | 08:30- 12:30 | Posters - Poster Zone C | Non coronary cardiac interventions |
| 28 Aug 2011 | Controversies in secondary stroke prevention | 11:00- 12:30 | Berlin - Zone F | Non coronary cardiac interventions |
| 28 Aug 2011 | Poster session 1: New technical approaches in stenting | 08:30- 12:30 | Posters - Poster Zone C | PCI / stents: devices and technique |
| 28 Aug 2011 | Dilemmas in percutaneous coronary intervention | 11:00- 12:30 | The Hague - Zone A | PCI / stents: devices and technique |
| 28 Aug 2011 | Percutaneous coronary intervention in 3 vessel disease and main stem | 12:45- 13:45 | Belgrade - Zone F | PCI / stents: devices and technique |
| 28 Aug 2011 | Myocardial revascularisation for chronic total coronary oclusion | 08:30- 10:00 | Belgrade - Zone F | PCI: lesion / patient subsets |
| 28 Aug 2011 | Repeat revascularisation after bypass surgery: a real challenge | 08:30- 10:00 | Berlin - Zone F | PCI: lesion / patient subsets |
| 28 Aug 2011 | Controversies in gender-related differences in cardiovascular disease | 16:30- 18:00 | Riga - Zone B | PCI: lesion / patient subsets |
| 28 Aug 2011 | Unprotected left main disease in 2011 | 16:30- 18:00 | Berlin - Zone F | PCI: lesion / patient subsets |
| 28 Aug 2011 | Poster session 2: Long term follow up after percutaneous coronary intervention | 14:00- 18:00 | Posters - Poster Zone C | PCI: longterm outcome |
| 28 Aug 2011 | Poster session 2: Challenging percutaneous coronary intervention on the long term | 14:00- 18:00 | Posters - Poster Zone C | PCI: longterm outcome |
| 28 Aug 2011 | Poster session 2: Percutaneous coronary intervention: efficacity of proof on the long run | 14:00- 18:00 | Posters - Poster Zone C | PCI: longterm outcome |
| 28 Aug 2011 | Perioperative management after coronary stenting | 11:00- 12:30 | Belgrade - Zone F | PCI: longterm outcome |
| 28 Aug 2011 | Case - based learning from the ESC Cardiologists of Tomorrow: "disasters in the cath lab" | 11:00- 12:30 | Scene@ESC 2 - Zone C | PCI: procedural complications |
| 28 Aug 2011 | Complications during percutaneous cardiovascular interventions | 14:00- 15:30 | London - Zone A | PCI: procedural complications |
| 28 Aug 2011 | Dealing with major complications during percutaneous coronary intervention | 16:30- 18:00 | Belgrade - Zone F | PCI: procedural complications |
| 28 Aug 2011 | Poster session 2: Thrombosis in cardiovascular disorders: insights into mechanisms | 14:00- 18:00 | Posters - Poster Zone C | Thrombosis and platelets |
| 28 Aug 2011 | A new look at platelets | 08:30- 10:00 | Ankara - Zone F | Thrombosis and platelets |
| 28 Aug 2011 | Emerging concepts of antiplatelet treatment | 14:00- 15:30 | Ankara - Zone F | Thrombosis and platelets |
| 28 Aug 2011 | Interface between antiplatelet therapy and general medical conditions | 14:00- 15:30 | Tunis - Zone F | Thrombosis and platelets |
| 28 Aug 2011 | Controversial issues in therapy | 16:30- 18:00 | Zagreb - Zone F | Thrombosis and platelets |
| 29 Aug 2011 | Poster session 4: Stable coronary disease | 14:00- 18:00 | Posters - Poster Zone C | Angina pectoris stable |
| 29 Aug 2011 | Are we doing enough to lower heart rate in Ischaemia Heart Disease? | 11:00- 12:30 | Sofia - Zone B | Angina pectoris stable |
| 29 Aug 2011 | The challenge of refractory angina | 14:00- 15:30 | Athens - Zone F | Angina pectoris stable |
| 29 Aug 2011 | New non ST-elevation-acute coronary syndrome Guidelines | 16:30- 18:00 | Oslo - Zone B | Angina pectoris unstable |
| 29 Aug 2011 | Optimising antithrombotic therapy: a tailored approach? | 12:45- 13:45 | Ankara - Zone F | Antithrombotic agents |
| 29 Aug 2011 | Guidance of antiplatelet treatment | 16:30- 18:00 | Berlin - Zone F | Antithrombotic agents |
| 29 Aug 2011 | Advancing stroke prevention in atrial fibrillation.The emerging role of Factor Xa inhibition | 18:30- 20:00 | Warsaw - Zone A | Antithrombotic agents |
| 29 Aug 2011 | Update on cardiovascular surgery | 10:00- 11:00 | Moderated Posters - Poster Zone C | Aorta, peripheral arterial and venous surgery |
| 29 Aug 2011 | Aortic stenosis: new insights from bench to bedside | 11:00- 12:30 | Beirut - Zone E | Aortic valve disease |
| 29 Aug 2011 | The aortic root and valve: management implications | 11:00- 12:30 | Cairo - Zone E | Aortic valve disease |
| 29 Aug 2011 | Transcatheter aortic valve implantation; where do we stand? | 12:45- 13:30 | Belgrade - Zone F | Aortic valve disease |
| 29 Aug 2011 | Heart rate lowering in coronary artery disease management | 18:30- 20:00 | London & The Hague - Zone A | CAD and comorbidities |
| 29 Aug 2011 | Poster session 3: Acute coronary syndromes: lessons from the cath lab | 08:30- 12:30 | Posters - Poster Zone C | Infarction acute phase non STEMI |
| 29 Aug 2011 | Management of acute coronary syndromes in high-risk patients | 11:00- 12:30 | Athens - Zone F | Infarction acute phase non STEMI |
| 29 Aug 2011 | Biomarkers that complete the picture for acute cardiovascular conditions in the emergency department: the role of B-type natriuretic peptide in ACS and NGAL in acute decompensated heart failure | 12:45- 13:30 | Sofia - Zone B | Infarction acute phase non STEMI |
| 29 Aug 2011 | Impact of cardiogoniometry for identification of patients with stable coronary artery disease (CAD) and acute myocardial ischemia. | 12:45- 13:30 | Copenhagen - Zone D | Infarction acute phase non STEMI |
| 29 Aug 2011 | High sensitive troponin T and N-terminal natriuretic peptide type B: from acute coronary syndrome to heart failure | 12:45- 13:30 | Bratislava - Zone E | Infarction acute phase non STEMI |
| 29 Aug 2011 | Controversial issues in acute coronary syndromes | 08:30- 10:00 | Athens - Zone F | Infarction acute phase STEMI |
| 29 Aug 2011 | Detection and assessment of myocardial infarction | 08:30- 10:00 | Paris - Zone F | Infarction acute phase STEMI |
| 29 Aug 2011 | Convergence of generations in myocardial infarction management: from 'old' therapies to 'new' technologies | 14:00- 15:30 | Zagreb - Zone F | Infarction acute phase STEMI |
| 29 Aug 2011 | Poster session 3: Invasive coronary imaging | 08:30- 12:30 | Posters - Poster Zone C | Invasive coronary imaging |
| 29 Aug 2011 | Invasive coronary imaging in daily practice | 15:40- 16:20 | Athens - Zone F | Invasive coronary imaging |
| 29 Aug 2011 | Poster session 4: Novel experimental and clinical insights on mechanism in ischaemia and inflammation | 14:00- 18:00 | Posters - Poster Zone C | Ischaemia, experimental studies |
| 29 Aug 2011 | New mechanisms and targets in ischaemia | 10:00- 11:00 | Moderated Posters - Poster Zone C | Ischaemia, experimental studies |
| 29 Aug 2011 | Novel strategies for cardioprotection: lost in translation? | 16:30- 18:00 | Athens - Zone F | Ischaemia, experimental studies |
| 29 Aug 2011 | Poster session 4: New insights in stroke 1 | 14:00- 18:00 | Posters - Poster Zone C | Non coronary cardiac interventions |
| 29 Aug 2011 | Poster session 3: Percutaneous coronary interventions: technique and new devices | 08:30- 12:30 | Posters - Poster Zone C | PCI / stents: devices and technique |
| 29 Aug 2011 | Controversies in primary percutaneous coronary intervention | 08:30- 10:00 | Belgrade - Zone F | PCI / stents: devices and technique |
| 29 Aug 2011 | Fractional flow reserve is mandatory for the treatment of multivessel disease | 11:00- 12:30 | Belgrade - Zone F | PCI / stents: devices and technique |
| 29 Aug 2011 | The optimal treatment for acute myocardial infarction patients - Which stent to choose and the impact of your stent choice on dual antiplatlet therapy duration? | 12:45- 13:30 | Tel Aviv - Zone A | PCI / stents: devices and technique |
| 29 Aug 2011 | Difficult decisions in percutaneous myocardial revascularisation - Live from France | 08:30- 10:00 | London - Zone A | PCI: lesion / patient subsets |
| 29 Aug 2011 | Treatment of lesions at bifurcations | 11:00- 12:30 | Berlin - Zone F | PCI: lesion / patient subsets |
| 29 Aug 2011 | ESC Andreas Gruentzig Lecture on Interventional Cardiology | 17:15- 18:00 | Stockholm - Zone A | PCI: lesion / patient subsets |
| 29 Aug 2011 | ESC Rene Laennec Lecture on Clinical Cardiology | 14:45- 15:30 | Stockholm - Zone A | PCI: longterm outcome |
| 29 Aug 2011 | State of the Art - Old challenges in interventional cardiology: new answers from very large multicenter studies | 16:30- 18:00 | Tunis - Zone F | PCI: longterm outcome |
| 29 Aug 2011 | Poster session 3: Diagnosis preventions and management of percutaneous coronary intervention complications | 08:30- 12:30 | Posters - Poster Zone C | PCI: procedural complications |
| 29 Aug 2011 | Drug-eluting stent thrombosis in 2011: still an issue? | 14:00- 15:30 | Berlin - Zone F | PCI: procedural complications |
| 29 Aug 2011 | Strategies for stem cell-based heart repair | 11:00- 12:30 | Tel Aviv - Zone A | Stem cells and cell therapy |
| 29 Aug 2011 | Poster session 3: Acute coronary syndromes: risk stratification, medical therapy and follow-up | 08:30- 12:30 | Posters - Poster Zone C | Thrombolysis and mechanical reperfusion |
| 29 Aug 2011 | Platelet reactivity testing: applying the evidence in practice | 12:45- 13:30 | Moscow - Zone B | Thrombosis and platelets |
| 29 Aug 2011 | State of the Art - Antiplatelet therapy: clinical, genetic and platelet determinants of risk | 16:30- 18:00 | Ankara - Zone F | Thrombosis and platelets |
| 29 Aug 2011 | Latest non ST-elevation myocardial infarction (NSTEMI) guidelines: what's up? From trial data to clinical practice | 18:30- 20:00 | Belgrade - Zone F | Thrombosis and platelets |
| 29 Aug 2011 | Challenges of in-stent restenosis | 08:30- 10:00 | Berlin - Zone F | Restenosis |
| 29 Aug 2011 | Restenosis: new insights | 15:30- 16:30 | Moderated Posters - Poster Zone C | Restenosis |
| 30 Aug 2011 | Controversial issues in myocardial revascularisation | 08:30- 10:00 | Berlin - Zone F | Angina pectoris stable |
| 30 Aug 2011 | Multimodality imaging in patients with coronary artery disease - Live from Spain | 11:00- 12:30 | London - Zone A | Angina pectoris stable |
| 30 Aug 2011 | Ranolazine: from late INa+ to ischemia inhibition | 12:45- 13:30 | Bucharest - Zone E | Angina pectoris stable |
| 30 Aug 2011 | A new paradigm in the treatment of ischaemic heart disease | 16:30- 18:00 | Belgrade - Zone F | Angina pectoris stable |
| 30 Aug 2011 | Poster session 5: Acute coronary syndrome | 08:30- 12:30 | Posters - Poster Zone C | Angina pectoris unstable |
| 30 Aug 2011 | Poster session 5: Presentation, diagnosis and prognosis of aortic valve disease | 08:30- 12:30 | Posters - Poster Zone C | Aortic valve disease |
| 30 Aug 2011 | Poster session 6: Transcatheter aortic valve implantation - clinical | 14:00- 18:00 | Posters - Poster Zone C | Aortic valve disease |
| 30 Aug 2011 | Congenital aortic valve disease and aortopathy: recent advances | 11:00- 12:30 | Cairo - Zone E | Aortic valve disease |
| 30 Aug 2011 | Transcatheter aortic valve implantation (TAVI) for high risk patients with severe aortic stenosis | 14:00- 15:30 | Warsaw - Zone A | Aortic valve disease |
| 30 Aug 2011 | Atrial fibrillation and Ischaemic Heart Disease | 08:30- 10:00 | Riga - Zone B | CAD and comorbidities |
| 30 Aug 2011 | A fresh look at old and new risk factors | 08:30- 10:00 | Ankara - Zone F | CAD and comorbidities |
| 30 Aug 2011 | Outcome, procedures and treatment in acute coronary syndrome | 10:00- 11:00 | Moderated Posters - Poster Zone C | Infarction acute phase non STEMI |
| 30 Aug 2011 | Poster session 6: Stemi: management and outcome | 14:00- 18:00 | Posters - Poster Zone C | Infarction acute phase STEMI |
| 30 Aug 2011 | Primary percutaneous coronary intervention: from evidence to practice | 08:30- 10:00 | Athens - Zone F | Infarction acute phase STEMI |
| 30 Aug 2011 | Controversial issues on late-comers with STEMI | 11:00- 12:30 | Athens - Zone F | Infarction acute phase STEMI |
| 30 Aug 2011 | Meet the Trialist V - CRISP AMI | 12:45- 13:30 | Berne - Zone E | Infarction acute phase STEMI |
| 30 Aug 2011 | Poster session 6: Non invasive and invasive coronary imaging | 14:00- 18:00 | Posters - Poster Zone C | Invasive coronary imaging |
| 30 Aug 2011 | The best of the European Heart Journal - Acute coronary syndrome | 10:05- 10:55 | Sofia - Zone B | Ischaemia, experimental studies |
| 30 Aug 2011 | You need plumbers and electricians to build a house | 11:00- 12:30 | Riga - Zone B | Non coronary cardiac interventions |
| 30 Aug 2011 | Transcatheter mitral valve repair therapy: what have we learned so far? | 14:00- 15:30 | Stockholm - Zone A | Non coronary cardiac interventions |
| 30 Aug 2011 | The great debate - Left main in 2011: CABG or PCI? | 08:30- 10:00 | London - Zone A | PCI: lesion / patient subsets |
| 30 Aug 2011 | Poster session 5: Long-term outcome after drug eluting stenting | 08:30- 12:30 | Posters - Poster Zone C | PCI: longterm outcome |
| 30 Aug 2011 | Predictors of outcome in high risk coronary interventions | 08:30- 10:00 | Tunis - Zone F | PCI: longterm outcome |
| 30 Aug 2011 | Post myocardial infarction - can we do more? | 11:00- 12:30 | Ankara - Zone F | Post infarction period |
| 30 Aug 2011 | Poster session 6: The changing structure of the growning heart | 14:00- 18:00 | Posters - Poster Zone C | Stem cells and cell therapy |
| 30 Aug 2011 | Poster session 6: Stem cells - Do all roads load to regeneration? | 14:00- 18:00 | Posters - Poster Zone C | Stem cells and cell therapy |
| 30 Aug 2011 | Antiplatelet therapy: how, why, when | 11:00- 12:30 | Berlin - Zone F | Thrombosis and platelets |
| 30 Aug 2011 | Poster session 5: New insights in coronary interventions (Part II) | 08:30- 12:30 | Posters - Poster Zone C | Restenosis |
| 31 Aug 2011 | Controversial issues in patients with stable ischaemic heart disease | 11:00- 12:30 | Athens - Zone F | Angina pectoris stable |
| 31 Aug 2011 | Angiography, biochemical and electrocardiographic determinants of plaque instability | 08:30- 10:00 | Ankara - Zone F | Angina pectoris unstable |
| 31 Aug 2011 | Poster session 7: Miscellaneous | 08:30- 12:30 | Posters - Poster Zone C | Aortic valve disease |
| 31 Aug 2011 | Aortic stenosis in the elderly: difficulties for the clinician | 08:30- 10:00 | Bucharest - Zone E | Aortic valve disease |
| 31 Aug 2011 | Poster session 7: STEMI: pathophysiology, diagnosis and risk factors | 08:30- 12:30 | Posters - Poster Zone C | Infarction acute phase STEMI |
| 31 Aug 2011 | Novel insights in STEMI diagnosis and management | 11:00- 12:30 | Ankara - Zone F | Infarction acute phase STEMI |
| 31 Aug 2011 | Clinical correlates of plaque morphology assessed by invasive coronary imaging | 11:00- 12:30 | Zagreb - Zone F | Invasive coronary imaging |
| 31 Aug 2011 | Poster session 7: Coronary and non-coronary complications during percutaneous coronary intervention | 08:30- 12:30 | Posters - Poster Zone C | PCI / stents: devices and technique |
| 31 Aug 2011 | Consistent benefit of drug eluting stents in high-risk percutaneous coronary intervention | 08:30- 10:00 | Zagreb - Zone F | PCI / stents: devices and technique |
| 31 Aug 2011 | Poster session 7: Percutaneous coronary intervention lesion/patient subsets | 08:30- 12:30 | Posters - Poster Zone C | PCI: lesion / patient subsets |
| 31 Aug 2011 | Poster session 7: Cardiovascular surgery update | 08:30- 12:30 | Posters - Poster Zone C | PCI: lesion / patient subsets |
| 31 Aug 2011 | The grey zone of coronary intervention. | 11:00- 12:30 | Tunis - Zone F | PCI: lesion / patient subsets |
| 31 Aug 2011 | Strategies to improve patient safety during percutaneous coronary intervention | 08:30- 10:00 | Belgrade - Zone F | PCI: procedural complications |
| 31 Aug 2011 | Myocardial regeneration: searching for the magic key | 10:00- 11:00 | Moderated Posters - Poster Zone C | Stem cells and cell therapy |
| 31 Aug 2011 | Is there a need to tailor antiplatelet therapy in diabetes? | 08:30- 10:00 | Athens - Zone F | Thrombosis and platelets |